Informação sobre produto
- [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12R*,13R*)]-3-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetr ahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]pentadecanoic
Seco-erythromycin is a semisynthetic antibiotic that belongs to the group of macrolides. It is used in life science research and as a medicine for infections caused by bacteria, viruses, and parasites. Seco-erythromycin has been shown to have antibacterial, antifungal, antiviral, antiparasitic, and antimicrobial activity against microorganisms. It was originally isolated from Streptomyces erythreus. The compound was synthesized in 1955 by Dr. Paul Janssen in his laboratory at Janssen Pharmaceutica NV (now Johnson & Johnson).
Propriedades químicas
Consulta técnica sobre: 3D-AS16853 seco erythromycin
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
